PARG mRNA expression was upregulated in the presence of the synthetic androgen methyltrienalone (R1881) in LNCaP cells (Fig. 1b) and with DHT treatment in the independently derived LNCaP and LAPC4 prostate cancer cell lines (Supplementary Fig. 2a,b). The gene discussed is PARG; the disease is prostate cancer.